•
Sep 30, 2020

Transdigm Q4 2020 Earnings Report

Transdigm's Q4 2020 earnings were significantly impacted by the COVID-19 pandemic, with net sales decreasing by 23.9% and adjusted EPS decreasing by 48.6%.

Key Takeaways

TransDigm Group's Q4 2020 results were significantly impacted by the COVID-19 pandemic. Net sales decreased by 23.9% to $1,173 million, and adjusted earnings per share decreased by 48.6% to $2.89. Despite these challenges, the company was able to sequentially expand its EBITDA As Defined margin to about 42.4% through careful cost management.

Net sales decreased by 23.9% to $1,173 million.

Earnings per share from continuing operations was $1.76.

Adjusted earnings per share decreased by 48.6% to $2.89.

EBITDA As Defined margin was 42.4%.

Total Revenue
$1.17B
Previous year: $1.54B
-23.9%
EPS
$2.89
Previous year: $5.62
-48.6%
Gross Profit
$536M
Cash and Equivalents
$4.72B
Free Cash Flow
$179M
Total Assets
$0

Transdigm

Transdigm

Forward Guidance

Given the considerable uncertainty around the extent and duration of business disruptions related to the COVID-19 pandemic, and how that will impact operations, the Company will not provide fiscal year 2021 guidance at this time.